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Distal renal tubular acidosis without renal
impairment after use of tenofovir: a case
report
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Abstract
Background: Tenofovir, one of antiretroviral medication to treat human immunodeficiency virus (HIV) infection,
is known to cause proximal renal tubular acidosis such as Fanconi syndrome, but cases of distal renal tubular
acidosis had never been reported.
Case presentation: A 20-year-old man with HIV infection developed nausea and vomiting without diarrhea after
starting antiretroviral therapy. Arterial blood gas revealed non-anion-gap metabolic acidosis and urine test showed
positive urine anion gap. Tenofovir, one of antiretroviral medicine the patient received, was considered to be the
cause of this acidosis and all antiretroviral drugs were discontinued. Symptoms disappeared promptly without
recurrence of symptoms after resuming antiretroviral medications without tenofovir.
Conclusion: Distal renal tubular acidosis caused by tenofovir, without renal impairment is very rare. Since causes
of nausea and vomiting among HIV/AIDS patients are very diverse, awareness of this phenomenon is useful in
diagnosing and managing the problem.
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Background
Causes of nausea and vomiting among patients with
human immunodeficiency virus (HIV) infection and/or
acquired immune deficiency syndrome (AIDS) are di-
verse; gastrointestinal, neurological, endocrine causes to
name a few [1]. Nephrotoxicity and proximal renal tubu-
lar acidosis (RTA) known as Fanconi syndrome are
known and established side effect of tenofovir (TDF), a
nucleotide analog [2–5]. One study reported that the in-
cidence rate of moderate or severe renal insufficiency
caused by tenofovir was 29.2 and 2.2 cases per 1000
person-year respectively [6]. Fanconi syndrome caused
by tenofovir is rare and exact incidence rate is not
known. Fanconi syndrome caused by tenofovir is usually
associated with other manifestations such as worsening
of glomerular filtration rate (GFR), proteinuria, hypo-
phosphataemia, and glycosuria [4, 5].
RTA can be differentiated into either distal or
proximal, depending on the site of tubules affected. Both
have normal serum anion gap, but distal RTA is
characterized by positive urine anion gap ([Na+ + K+]u –
[Cl−]u), whereas proximal RTA has negative urine anion
gap [7]. Major causes of distal RTA in adults is
autoimmune diseases such as Sjögren’s syndrome [7].
Medications such as ibuprofen are also known to cause
distal RTA [8], but distal RTA caused by antiretroviral
medications has never been reported to the best of our
knowledge. We here present such a rare case of distal
RTA most likely caused by tenofovir.
Case presentation
A 20-year-old man with HIV infection visited us with
chief complaint of nausea and vomiting. He had been
followed at our Infectious Diseases clinic. He had no
past medical history otherwise, including opportunistic
diseases. Two months after his initial visit, antiretroviral
therapy (ART) was started with Truvada ® (tenofovir and
emtricitabine), and raltegravir. His baseline CD4+ T
lymphocytes count before initiation of ART was 456/μL
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and RT-PCR for HIV-1 was 2.8 x 103 copies/mL. Other
routine blood and urine tests were all normal. He stated
that he had been adherent to ART. Six weeks after initi-
ation of ART, he developed nausea and vomiting. He vis-
ited our Infectious Diseases clinic on the following day.
He denied fever, headache, seizure, abdominal pain, or
diarrhea. He also denied use of medications other than
we prescribed, supplements, alcohol or any illicit drugs.
On physical examination, he appeared anxious. Blood
pressure was 116/70 mmHg, pulse rate 95/min, respira-
tory rate 18/min, and body temperature 36.9 °C. Rest of
physical examination including thorough neurological
examination was normal. On blood tests, complete
blood counts (CBC), electrolytes, liver and kidney
function tests were all unremarkable (Table 1). Arterial
blood gas showed pH 7.327, pCO2 38.3 mmHg, bicar-
bonate 19.3 mmol/L, and anion gap 13.9 mmol/L. Spot
urianalysis showed urine pH 5.5, and urine sodium
160 mmol/L, potassium 52 mmol/L, chloride 48 mmol/
L, with urine anion gap ([Na+ + K+]u – [Cl
−]u) of
164 mmol/L. Urine phosphorus was 138.4 mg/dL, urine
calcium was 31.9 mg/dL, and urine β2-microglobulin
was 1268 μg/L (normal range 0-289). Urine was also
positive for protein (1+) and ketone (3+). Urine specific
gravity was 1.032 with approximate urine osmolality of
1000 mOsm/kg [9]. Calculated urine osmolality (2 x
[Na + K]) + [urea nitrogen in mg/dL]/2.8 + [glucose in
mg/dL]/18) was 939 mOsm/kg [10], with approximate
urine osmolal gap of 61 mOsm/kg.
Non-anion-gap metabolic acidosis was considered to
be the cause of his current symptoms, and medications
were suspected as the causative agent. Intravenous
hydration and antiemetic was provided and all anti-
retroviral agents were discontinued at once. On the
following day, his symptoms disappeared. Venous
blood gas revealed normalized bicarbonate (Table 1).
Five days after this event, the patient re-started ART
with Epzicom ® (abacavir and lamivudine), and ralte-
glavir. He remains on the latest regimen without fur-
ther events. Four months after re-starting ART, his
CD4+ T lymphocytes count increased to 648/μL with
undetectable HIV-1RNA.
Tenofovir is known to cause drug induced Fanconi
syndrome, but is usually associated with other manifes-
tations, particularly worsening of glomerular filtration
rate. However, our patient lacked these symptoms, and
urine anion gap was positive, making proximal renal
tubular acidosis such as Fanconi syndrome less likely.
In our case, acute onset nausea and vomiting without
diarrhea, with non-anion-gap metabolic acidosis plus
positive urine anion-gap, makes distal renal tubular acid-
osis most likely. The reason for lack of potassium abnor-
mality in the patient remains unknown, but acute onset
of symptoms and prompt treatment might have
prevented significant potassium wasting, which is
characteristic of most distal RTA. We consider this
case is of distal RTA of unclassified type, with prompt
improvement after cessation of causative agent; i.e.
tenofovir. Since discontinuation of tenofovir was ef-
fective in prompt disappearance of symptoms and
acidosis, and re-institution of lamivudine (analogous
to emtricitabine. They are very similar both in struc-
ture and pharmacological properties) and raltegravir
did not cause the recurrence of the symptoms, we
considered tenofovir as the most likely cause of RTA
in this patient. We obtained venous blood gas to as-
certain the correction of acidosis since recent meta-
analysis found that venous gas is comparable to arter-
ial blood gas in evaluating pH [11].
This is the first case ever reported on such an occur-
rence as far as we know of. The exact mechanism of
renal toxicity caused by tenofovir is unknown, but it is
considered to be the result of proximal tubular toxicity
[12]. Pathogenesis of distal RTA by tenofovir, as in our
case, remains unknown. Diminished hydrogen adenosine
phosphatase (H-ATPase) activity is the most common
cause of distal RTA [13], and it might have occurred
with use of tenofovir. Although not reported so far,







While-cell count (per mm3) 4000–8500 5100
Hemoglobin (g/dL) 13.6–17 14.7
Platelet (per mm3) 130,000–
300,000
209,000
Sodium (mmol/L) 137–146 136
Potassium (mmol/L) 3.5–4.7 4.1
Chloride (mmol/L) 99–109 103
Calcium (mg/dL) 8.8–10.1 9.2
Phosphorus (mg/dL) 2.4–4.5 4.1







Total bilirubin (mg/dL) 0.3–1 1.2
Blood Urea Nitrogen (BUN)
(mg/dL)
9–22 19.3
Creatinine (mg/dL) 0.5–1.3 0.59
Blood gas (arterial) (venous)
pH 7.38–7.46 7.327 7.334




−) (mmol/L) 21–29 19.5 22.3
Anion-gap (mmol/L) 10–20 13.9 12.3
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other antiretroviral agents, particularly nucleoside/nu-
cleotide analogs also might cause similar side effect.
Further studies might reveal pathogenesis of this
phenomenon, as well as the true incidence and signifi-
cance of this side effect. In addition, use of newer and
apparently safer agent, tenofovir alafenamide (TAF) may
prevent this to occur [14].
Conclusions
We here present a rare case of distal RTA without renal
impairment most likely caused by tenofovir. Since causes
of nausea and vomiting among HIV/AIDS patients are
very diverse, awareness of this phenomenon is useful in
diagnosing and managing the problem.
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